Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer

Clinical trial NCT00267488 · COMPLETED

Trial details

NCT number: NCT00267488
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Endometrial Endometrial Cancer

Start date: 2005-10-01
Primary completion: 2007-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.